Prognostic value of metformin for non-small cell lung cancer patients with diabetes

BACKGROUND: The anti-cancer role of metformin has been reported in many different kinds of solid tumors, but how it affects non-small cell lung cancer (NSCLC) is currently elusive. The aim of this study was to investigate the influence of metformin treatment on diabetic NSCLC. METHODS: Two hundred f...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tongbai, Li, Dongsheng, He, Yuan, Zhang, Fuliang, Qiao, Man, Chen, Yanhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859437/
https://www.ncbi.nlm.nih.gov/pubmed/29558957
http://dx.doi.org/10.1186/s12957-018-1362-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859437/
https://www.ncbi.nlm.nih.gov/pubmed/29558957
http://dx.doi.org/10.1186/s12957-018-1362-1

Ejemplares similares